Список літератури
1. ERBP: Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min). Nephrology, Dialysis, Transplantation, 2016.
2. van der Veer S.N., van B.W., Bernaert P. et al. Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults. Int. Urol. Nephrol. 2016. 48. 859-869.
3. Nagler E.V., Webster A.C., Bolignano D. et al. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol. Dial. Transplant. 2014. 29. 731-738.
4. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2009 гг. Нефрология и диализ. 2009. 9(1). 6-85.
5. Смирнов А.В. и др. Хроническая болезнь почек: дальнейшее развитие концепции и классификации. Нефрология. 2007. Т. 11. № 4. C. 7-17.
6. Клинические практические рекомендации KDIGO 2012 по диагностике и лечению хронической болезни почек. Нефрология и диализ. 2017. Т. 19. № 1.
7. Poulikakos D., Banerjee D., Malik M. Risk of Sudden Cardiac Death in Chronic Kidney Disease. J. Cardiovasc. Electrophysiol. 2014 Feb. 25(2). 222-231.
8. Green D., Roberts P.R., New D.I. et al. Sudden cardiac death in hemodialysis patients: an in-depth review. Am. J. Kidney Dis. 2011. 57. 921-929.
9. Chandrashekar A., Ramakrishnan S., Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian Journal of Nephrology. 2014. № 24(4). Р. 206-213.
10. USRDS 2012 Annual Report: National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2012.
11. Pippias M., Stel V.S., Abad Diez J.M. et al. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin. Kidney J. 2015. № 8(3). Р. 248-261.
12. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int. Suppl. 2015. № 5(1). Р. 2-7.
13. Chen H.S., Cheng C.T., Hou C.C. et al. Survival and other clinical outcomes of maintenance hemodialysis patients in Taiwan: a 5-year multicenter follow-up study. Hemodialysis international International Symposium on Home. Hemodialysis. 2014. № 18(4). Р. 799-808.
14. Yamagata K., Nakai S., Iseki K., Tsubakihara Y. Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry. Ther. Apher. Dial. 2012. № 16(2). Р. 111-120.
15. Gaipov A., Issanov A., Kadyrzhanuly K. et al. Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018. BMC Nephrol. 2020. 21. 407(2020). https://doi.org/10.1186/s12882-020-02047-6.
16. Абрамова Е.Э., Королева И.Е., Тов Н.Л. и др. Факторы риска летальных исходов у больных на гемодиализе. Journal of Siberian Medical Sciences. 2015. № 6. С. 15-26.
17. Obi Y., Rhee C.M., Mathew A.T. et al. Residual kidney function decline and mortality in incident hemodialysis patients. J. Am. Soc. Nephrol. 2016. doi: 10.1681/ASN.2015101142.
18. Brener Z.Z., Kotanko P., Thijssen S. et al. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am. J. Med. Sci. 2010. № 339(5). Р. 453-456.
19. Vilar E., Farrington K. Emerging importance of residual renal function in end-stage renal failure. Semin. Dial. 2011. № 24(5). Р. 487-494.
20. Shafi T., Jaar B.G., Plantinga L.C. et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am. J. Kidney Dis. 2010. № 56. Р. 348-358.
21. Araujo S., Lemes H.P., Cunha D.A. et al. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis. J. Bras. Nefrol. 2011. № 33(1). Р. 74-81.
22. Tang W., Li L.X., Pei J., Wang T. Heart rate variability in peritoneal dialysis patients: what is the role of residual renal function? Blood Purif. 2012. № 34(1). Р. 58-66.
23. Chen Y., Liu H., Zou J. et al. 24-h residual urine volume at hemodialysis initiation: a possible predictor for acute ischemic stroke incurrence in hemodialysis patients. Clin. Neurol. Neurosurg. 2013. № 115(5). Р. 557-561.
24. Ma T., Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis. Ren. Fail. 2013. № 35(2). Р. 198-203.
25. Perl J., Bargman J.M. The importance of residual kidney function for patients on dialysis: a critical review. Am. J. Kidney Dis. 2009. № 53(6). Р. 1068-1081.
26. Amaral S., Hwang W., Fivush B. et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin. J. Am. Soc. Nephrol. 2008. № 3. Р. 759-767.
27. Combe C., McCullough K.P., Asano Y. et al. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am. J. Kidney Dis. 2004. № 44. Р. 39-46.
28. Cooper B.A., Penne E.L., Bartlett L.H., Pollock C.A. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am. J. Kidney Dis. 2004. № 43. Р. 61-66.
29. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet. 2000. № 356. Р. 930-933.
30. Liebman S.E., Lamontagne S.P., Huang L.S. et al. Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am. J. Kidney Dis. 2011. № 58. Р. 257-265.
31. Kessler M., Zannad F., Lehert P. et al. Predictors of cardiovascular events in patients with end-stage renal disease: An analysis from the Fosinopril in dialysis study. Nephrol. Dial. Transplant. 2007. № 22. Р. 3573-3579.
32. Суворов А.В., Зубеева Г.Н., Суслова О.А. и др. Нарушение ритма сердца и сердечно-сосудистый риск у больных с терминальной хронической почечной недостаточностью, находящихся на программном гемодиализе. Практическая медицина. 2013. № 3. С. 77-80.
33. Chung S.H., Han D.C., Noh H. et al. Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrol. Dial. Transplant. 2010. № 25. Р. 3742-3748.
34. Tong J., Liu M., Li H. et al. Mortality and associated risk factors in dialysis patients with cardiovascular disease. Kidney Blood Press Res. 2016. № 41. Р. 479-487. Available at: https://doi.org/10.1159/000443449.
35. Wang H.H., Hung S.Y., Sung J.M. et al. Risk of stroke in long-term dialysis patients compared with the general population. Am. J. Kidney Dis. 2014. 63. Р. 604-611.
36. Drew D.A., Sarnak M.J. Ischemic and hemorrhagic stroke: High incidence in hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 2014. № 63. Р. 547-548.
37. Wu C.K., Yang Y.H., Juang J.M. et al. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Medicine (Baltimore). 2015. № 94(3). e424.
38. Tang Y., Brooks J.M., Wetmore J.B., Shireman T.I. Association between higher rates of cardioprotective drug use and survival in patients on dialysis. Res. Social Adm. Pharm. 2015. № 11(6). Р. 824-843.
39. Mokoli V.M., Sumaili E.K., Lepira F.B. et al. Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa. BMC Nephrology. 2016. № 17. Р. 182. https://doi.org/10.1186/s12882-016-0401-9.
40. Билевич О.А., Овсянников Н.В. Оценка выживаемости больных, находящихся на программном гемодиализе, в зависимости от показателей функционального состояния сердечно-сосудистой системы. Современные проблемы науки и образования. 2015. № 6.
41. Dalrymple L.S., Mohammed S.M., Mu Y. et al. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin. J. Am. Soc. Nephrol. 2011. № 6(7). Р. 1708-1713.
42. Jung M.Y., Hwang S.Y., Hong Y.A. et al. Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients. Kidney Research and Clinical Practice. 2015. № 34(1). Р. 20-27.
43. Bradbury B.D., Fissell R.B., Albert J.M. et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin. J. Am. Soc. Nephrol. 2007. № 2. Р. 89-99.
44. Plantinga L.C., Fink N.E., Levin N.W. et al. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am. J. Kidney Dis. 2007. № 49. Р. 831-840.
45. Postorino M., Marino C., Tripepi G., Zoccali C. Calabrian Registry of Dialysis and Transplantation: Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol. Dial. Transplant. 2007. № 22. Р. 1377-1382.
46. Wolf M., Shah A., Gutierrez O. et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007. № 72. Р. 1004-1013.